Source comparison
Epithalon vs Epitalon: Research Applications and Dosing Contexts
In vitro telomerase assays Human fibroblast cultures, TRAP assay Lymphocyte cultures, telomere FISH 0.1–10 µM in serum-free media Telomerase activity fold-change, telomere length Pineal function studies Aged rodent models, circadian rhythm Photoperiod modulati
This comparison does not assign a generated winner or score.
- In vitro telomerase assays
- Human fibroblast cultures, TRAP assay
- Lymphocyte cultures, telomere FISH
- 0.1–10 µM in serum-free media
- Telomerase activity fold-change, telomere length
- Pineal function studies
- Aged rodent models, circadian rhythm
- Photoperiod modulation in rats
- 0.1–1.0 mg/kg subcutaneous
- Nocturnal melatonin peak amplitude
- Lifespan extension models
- C. elegans, Drosophila melanogaster
- Aged mice, spontaneous tumour rates
- 10–100 µg/mL culture media or 1 mg/kg
- Mean lifespan, maximum lifespan percentile
- Supplier catalogues
- Predominantly 'Epithalon' in US vendors
- 'Epitalon' in European peptide houses
- 2–10 mg per vial, lyophilised
- Purity ≥98% by HPLC, sequence confirmed
- Professional Assessment
- Both spellings refer to identical tetrapeptide; verify amino-acid sequence through third-party HPLC-MS rather than relying on nomenclature. Mechanism and purity are independent of transliteration.
- The table clarifies that epithalon peptide same as epitalon isn't a comparison of two compounds but a reconciliation of naming conventions across research geographies. Researchers sourcing the peptide should prioritise structural verification over spelling. A Certificate of Analysis confirming the Ala-Glu-Asp-Gly sequence through mass spectrometry is mandatory regardless of whether the supplier labels it Epithalon or Epitalon. Real Peptides synthesises research-grade tetrapeptides with batch-specific purity testing and exact amino-acid sequencing, ensuring structural consistency across catalogue entries. The concentration ranges listed reflect published protocols from peer-reviewed studies, not dosing recommendations. Experimental design must account for species differences, delivery method, and endpoint sensitivity when translating these ranges into novel research contexts.